Taken together, BMPR2 silencing in HPAECs leads to endothelial dysfunction as measured by increased cellular proliferation, viability, and cytokine release, which are all attenuated by inhibition of the nmMLCK pathway. This evidence concerns the gene BMPR2 and endothelial dysfunction.